Page last updated: 2024-10-31

metoprolol and Fetal Growth Retardation

metoprolol has been researched along with Fetal Growth Retardation in 5 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Fetal Growth Retardation: Failure of a FETUS to attain expected GROWTH.

Research Excerpts

ExcerptRelevanceReference
"We found a five-fold increased risk of delivering a small-for-gestational-age infant in women with heart disease treated with a high dose of beta-blocker, and a two-fold increased risk among those treated with a low dose, showing an apparent dose-response relation."1.72Maternal beta-blocker dose and risk of small-for gestational-age in women with heart disease. ( Estensen, ME; Haualand, R; Langesaeter, E; Letting, AS; Sørbye, IK; Wiull, H, 2022)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Sørbye, IK1
Haualand, R1
Wiull, H1
Letting, AS1
Langesaeter, E1
Estensen, ME1
Duan, L1
Ng, A1
Chen, W1
Spencer, HT1
Lee, MS1
Esposito, F1
Galfetti, M1
Lava, SA1
Balestra, B1
Bianchetti, MG1
Sandström, B2

Other Studies

5 other studies available for metoprolol and Fetal Growth Retardation

ArticleYear
Maternal beta-blocker dose and risk of small-for gestational-age in women with heart disease.
    Acta obstetricia et gynecologica Scandinavica, 2022, Volume: 101, Issue:7

    Topics: Female; Fetal Development; Fetal Growth Retardation; Heart Diseases; Humans; Infant; Infant, Newborn

2022
Beta-blocker subtypes and risk of low birth weight in newborns.
    Journal of clinical hypertension (Greenwich, Conn.), 2018, Volume: 20, Issue:11

    Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Birth Weight; California; Fem

2018
Fetopathy probably associated to self-medication with a blocker of the renin-angiotensin system.
    Archives of gynecology and obstetrics, 2011, Volume: 284, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers; Antimalarials; Cesarean

2011
Clinical trials of adrenergic antagonists in pregnancy hypertension.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1984, Volume: 118

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Apgar Score; Birth Weight; Female; Fetal Growt

1984
Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy.
    Gynecologic investigation, 1978, Volume: 9, Issue:4

    Topics: Apgar Score; Drug Evaluation; Drug Therapy, Combination; Female; Fetal Growth Retardation; Fetus; Hu

1978